These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 17297823)

  • 21. Efferent-mediated reduction in cochlear gain does not alter tuning estimates from stimulus-frequency otoacoustic emission group delays.
    Bhagat SP; Kilgore C
    Neurosci Lett; 2014 Jan; 559():132-5. PubMed ID: 24333175
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efferent feedback minimizes cochlear neuropathy from moderate noise exposure.
    Maison SF; Usubuchi H; Liberman MC
    J Neurosci; 2013 Mar; 33(13):5542-52. PubMed ID: 23536069
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of contralateral noise on distortion product latency in humans: is the medial olivocochlear efferent system involved?
    Giraud AL; Wable J; Chays A; Collet L; Chéry-Croze S
    J Acoust Soc Am; 1997 Oct; 102(4):2219-27. PubMed ID: 9348679
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hearing Without Neuroglobin.
    Nowotny M; Kiefer L; Andre D; Fabrizius A; Hankeln T; Reuss S
    Neuroscience; 2017 Dec; 366():138-148. PubMed ID: 29031607
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peripheral auditory tuning for vowels.
    Namasivayam AK; Le DJ; Hard J; Lewis SE; Neufeld C; van Lieshout P
    J Integr Neurosci; 2013 Dec; 12(4):461-74. PubMed ID: 24372066
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Contralateral Suppression of DPOAEs in Mice after Ouabain Treatment.
    Li J; Chen Y; Zeng S; Lai C; Zhang Y; Zhang L; Shi Y; Zhang T; Li H; Dai P
    Neural Plast; 2018; 2018():6890613. PubMed ID: 29849563
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Separating the contributions of olivocochlear and middle ear muscle reflexes in modulation of distortion product otoacoustic emission levels.
    Wolter NE; Harrison RV; James AL
    Audiol Neurootol; 2014; 19(1):41-8. PubMed ID: 24335024
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in amplitude and phase of distortion-product otoacoustic emission fine-structure and separated components during efferent activation.
    Henin S; Thompson S; Abdelrazeq S; Long GR
    J Acoust Soc Am; 2011 Apr; 129(4):2068-79. PubMed ID: 21476662
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Medial olivocochlear efferent activity in awake guinea pigs.
    Guitton MJ; Avan P; Puel JL; Bonfils P
    Neuroreport; 2004 Jun; 15(9):1379-82. PubMed ID: 15194856
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Medial olivocochlear efferent reflex inhibition of human cochlear nerve responses.
    Lichtenhan JT; Wilson US; Hancock KE; Guinan JJ
    Hear Res; 2016 Mar; 333():216-224. PubMed ID: 26364824
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of three hours of discotheque music on pure-tone thresholds and distortion product otoacoustic emissions.
    Müller J; Dietrich S; Janssen T
    J Acoust Soc Am; 2010 Oct; 128(4):1853-69. PubMed ID: 20968358
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interaural attention modulates outer hair cell function.
    Srinivasan S; Keil A; Stratis K; Osborne AF; Cerwonka C; Wong J; Rieger BL; Polcz V; Smith DW
    Eur J Neurosci; 2014 Dec; 40(12):3785-92. PubMed ID: 25302959
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Noise-induced hearing loss vulnerability in type III intermediate filament peripherin gene knockout mice.
    Cederholm JME; Parley KE; Perera CJ; von Jonquieres G; Pinyon JL; Julien JP; Ryugo DK; Ryan AF; Housley GD
    Front Neurol; 2022; 13():962227. PubMed ID: 36226085
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neurotoxicity of BFM-95 on the medial olivocochlear bundle assessed by means of contralateral suppression of 2f1-f2 distortion product otoacoustic emissions.
    Riga M; Korres S; Psarommatis I; Varvutsi M; Giotakis I; Papadas T; Ferekidis E; Apostolopoulos N
    Otol Neurotol; 2007 Feb; 28(2):208-12. PubMed ID: 17255889
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Distortion-product otoacoustic emissions and contralateral suppression findings in children with Asperger's Syndrome.
    Kaf WA; Danesh AA
    Int J Pediatr Otorhinolaryngol; 2013 Jun; 77(6):947-54. PubMed ID: 23562236
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of contralateral sound stimulation on the distortion product 2F1-F2: evidence that the medial efferent system is involved.
    Puel JL; Rebillard G
    J Acoust Soc Am; 1990 Apr; 87(4):1630-5. PubMed ID: 2341667
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Age-related decline in Kv3.1b expression in the mouse auditory brainstem correlates with functional deficits in the medial olivocochlear efferent system.
    Zettel ML; Zhu X; O'Neill WE; Frisina RD
    J Assoc Res Otolaryngol; 2007 Jun; 8(2):280-93. PubMed ID: 17453307
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Contralateral suppression of distortion-product otoacoustic emissions: a potential diagnostic tool to evaluate the vestibular nerve.
    Chang MY; Song JJ; Kim JS; Koo JW
    Med Hypotheses; 2013 Nov; 81(5):830-3. PubMed ID: 24074898
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contralateral acoustic stimulation modulates low-frequency biasing of DPOAE: efferent influence on cochlear amplifier operating state?
    Abel C; Wittekindt A; Kössl M
    J Neurophysiol; 2009 May; 101(5):2362-71. PubMed ID: 19279155
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Distortion product otoacoustic emission test performance when both 2f1-f2 and 2f2-f1 are used to predict auditory status.
    Gorga MP; Nelson K; Davis T; Dorn PA; Neely ST
    J Acoust Soc Am; 2000 Apr; 107(4):2128-35. PubMed ID: 10790038
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.